Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina.
Department of Health Services, University of Washington, Seattle, Washington.
J Cardiovasc Electrophysiol. 2019 May;30(5):709-716. doi: 10.1111/jce.13875. Epub 2019 Feb 19.
We evaluated the association between a novel electrocardiographic (ECG) marker of late, rightward electrocardiographic forces (termed the lead one ratio [LOR]), and left ventricular ejection fraction (LVEF), myocardial scar, and clinical outcomes in patients with left bundle branch block (LBBB).
LOR was calculated in patients with LBBB from a derivation cohort (n = 240) and receiver operator characteristic curves identified optimal threshold values for predicting myocardial scar and LVEF less than 35%. An independent validation cohort of patients with LBBB (n = 196) was used to test the association of LOR with the myocardial scar, LVEF, and the likelihood of death, heart transplant or left ventricular assist device (LVAD) implantation. The optimal thresholds in the derivation cohort were LOR less than 13.7 for identification of scar (sensitivity 55%, specificity 80%), and LOR less than 12.1 for LVEF less than 35% (sensitivity 49%, specificity 80%). In the validation cohort, LOR less than 13.7 was not associated with scar size or presence (P > 0.05 for both). LOR less than 12.1 was associated with lower LVEF (30 [20-40] versus 40 [25-55]%; P = 0.002) and predicted LVEF less than 35% in univariable (odds ratio [OR], 2.2 [1.2-4.1]; P = 0.01) and multivariable analysis (OR, 2.2 [1.2-4.3]; P = 0.02). LOR less than 12.1 was associated with scar presence when patients with nonischemic cardiomyopathy were excluded (OR = 7.2 [1.5-33.2]; P = 0.002). LOR less than 12.1 had an adjusted hazard ratio of 1.53 ([1.05-2.21]; P = 0.03) for death, transplant or LVAD implantation.
In conclusion, ECG LOR less than 12.1 predicts reduced-LV systolic function and poorer prognosis in patients with LBBB.
我们评估了一种新的心电图(ECG)标记物——晚期右向心电图力(称为导联比[LOR])与左束支传导阻滞(LBBB)患者左心室射血分数(LVEF)、心肌瘢痕和临床结局之间的关系。
从一个推导队列(n=240)中计算 LBBB 患者的 LOR,并使用接收器操作特征曲线确定预测心肌瘢痕和 LVEF 小于 35%的最佳阈值值。使用一个独立的 LBBB 患者验证队列(n=196)来检验 LOR 与心肌瘢痕、LVEF 以及死亡、心脏移植或左心室辅助装置(LVAD)植入的可能性之间的关联。在推导队列中,LOR 小于 13.7 用于识别瘢痕(敏感性 55%,特异性 80%),LOR 小于 12.1 用于识别 LVEF 小于 35%(敏感性 49%,特异性 80%)。在验证队列中,LOR 小于 13.7 与瘢痕大小或存在无关(两者均 P>0.05)。LOR 小于 12.1 与较低的 LVEF 相关(30 [20-40] 与 40 [25-55]%;P=0.002),并在单变量(比值比[OR],2.2 [1.2-4.1];P=0.01)和多变量分析(OR,2.2 [1.2-4.3];P=0.02)中预测 LVEF 小于 35%。当排除非缺血性心肌病患者时,LOR 小于 12.1 与瘢痕存在相关(OR=7.2 [1.5-33.2];P=0.002)。LOR 小于 12.1 的调整后风险比为 1.53([1.05-2.21];P=0.03),用于死亡、移植或 LVAD 植入。
总之,ECG LOR 小于 12.1 预测 LBBB 患者左心室收缩功能降低和预后不良。